Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress

Rheumatology

Volumn 42, Issue 10, 2003, Pages 1234-1241

  Nagler, R M ^a   Salameh, F ^a   Reznick, A Z ^a   Livshits, V ^a   Nahir, A M ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Antioxidants; Ceruloplasmin; Creatinine; Malondialydehyde; Peroxidase; Rheumatoid arthritis; Saliva; Total antioxidant status; Uric acid

Indexed keywords

ANTIOXIDANT; CERULOPLASMIN; CREATININE; FREE RADICAL; MALONALDEHYDE; PEROXIDASE; RHEUMATOID FACTOR; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; FLOW RATE; HUMAN; MALE; MEDICAL ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SALIVA ANALYSIS; SALIVARY GLAND; SALIVATION;

ADULT; AGE DISTRIBUTION; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; CERULOPLASMIN; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; SALIVA; SALIVATION; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; URIC ACID;

EID: 0141962666     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg362     Document Type: Article

References (29)

1. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl J Med 1990;322: 1277-89.
2. Strand V. Recent advances in the treatment of rheumatoid arthritis. Clin Cornerstone 1999;2:38-50.
3. Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001;306:1-17.
4. Darlington LG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr 2001;85:251-69.
5. Mantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45-58.
6. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation. Clin Biochem 1997;30:351-5.
7. Kiziltunc A, Cogalgil S, Cerrahoglu L. Carnitine and antioxidant levels in patients with rheumatoid arthritis. Scand J Rheumatol 1998;27:441-5.
8. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999;19:35-7.
9. Biemond P, Swaak AJG, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthritis Rheum 1984;27:760-5.
10. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995;54: 505-10.
11. Honkanen V, Konttinen YT, Mussalo-Rauhamaa H. Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol 1990-8:616-7.
12. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994;53:51-3.
13. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-44.
14. Halliwell B, Hoult JR, Blake DR. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 1988;2: 2867-73.
15. Blake DR, Merry P, Unsworth J et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;1(8633):289-93.
16. Sullivan S, Fernandes L, McFarlance IG et al. Impairment of lacrimal and salivary secretion and cellular immune responses to salivary antigens in rheumatoid arthritis. Ann Rheum Dis 1978;37:164-7.
17. Markkanen SO, Syrjanen SM, Lappalainen R, Markkanen H. Assessment of labial salivary gland changes in patients with rheumatoid arthritis by subjective and quantitative methods. Appl Pathol 1989;7:233-40.
18. Grevers G, Spath M, Kruger K, Schattenkirchner M. Immuno-diagnostic findings in 'secondary' Sjogren syndrome in chronic polyarthritis. Laryngo rhino otologie 1990;69: 605-7.
19. Zhang H, Shi GY, Cai XH. Detection of serum antisalivary duct antibody and its clinical significance. Zhonghua Nei Ke Za Zhi 1990;29:666-8.
20. Livshitz V, Nahir AM. Steroids normalize ceruloplasmin ferroxidase activity in rheumatoid arthritis. Int J Med Biol Environ 2000;28:183-9.
21. Nagler RM, Nagler A. Pilocarpine hydrochloride (Salagen) relieves xerostomia in chronic graft versus host disease patients. Bone Marrow Transplant 1993;23:1007-11.
22. Nagler RM, Marmary Y, Krausz Y. Salivary gland dysfunction in human acute and chronic graft versus host disease (GVHD). Bone Marrow Transplant 199617:219-24.
23. Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 1961;58:161-8.
24. Slater TF, Sawyer BC. The stimulatory effect of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vivo. Biochem J 1971;123:805-4.
25. Reznick AZ, Klein Y, Eisfrich JP, Cross EC, Nagler R. Inhibition of oral peroxidase activity by cigarette smoke: in vivo and in vitro studies. Free Rad Biol Med. 2003;34:377-84.
26. Nagler R, Klein Y, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Rad Biol Med 2002;32; 268-77.
27. Nagler R, Hershkovich O, Lischinsky S, Diamond E, Reznick AZ. Saliva analysis in the clinical setup - revisiting an underutilized diagnostic tool. J Invest Med 200;250:214-25.
28. Moore S, Calder KAC, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and periodontal disease. Free Rad Res 1994;21:417-25.
29. Nagler R, Barak M, Ben-Aryeh H, Peled M, Filatov M, Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 1999;35:1018-25.